The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease
β Scribed by Franco Scaldaferri; Miquel Sans; Stefania Vetrano; Carmen Correale; Vincenzo Arena; Nico Pagano; Giacomo Rando; Fabio Romeo; Angelo E. Potenza; Alessandro Repici; Alberto Malesci; Silvio Danese
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 441 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi
Elevated immune responses to the enteric microbiota have long been associated with inflammatory bowel disease (IBD), especially Crohn's disease. In recent years there has been considerable progress in identifying a number of the specific bacterial and host molecules whose interactions mediate these
Background: Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support in choosing candidates for endoscopy. The value of 100 lg/g was recently assumed as the best cutoff for this assay. The purpose of this study